annual operating expenses:
$432.74M+$5.09M(+1.19%)Summary
- As of today (September 17, 2025), FOLD annual total operating expenses is $432.74 million, with the most recent change of +$5.09 million (+1.19%) on December 31, 2024.
- During the last 3 years, FOLD annual operating expenses has fallen by -$32.02 million (-6.89%).
- FOLD annual operating expenses is now -11.63% below its all-time high of $489.72 million, reached on December 31, 2022.
Performance
FOLD Operating expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly operating expenses:
$145.39M+$25.73M(+21.50%)Summary
- As of today (September 17, 2025), FOLD quarterly total operating expenses is $145.39 million, with the most recent change of +$25.73 million (+21.50%) on June 30, 2025.
- Over the past year, FOLD quarterly operating expenses has increased by +$47.13 million (+47.97%).
- FOLD quarterly operating expenses is now -14.52% below its all-time high of $170.09 million, reached on September 30, 2018.
Performance
FOLD quarterly operating expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Operating expenses Formula
Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses
FOLD Operating expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +1.2% | +48.0% |
| 3 y3 years | -6.9% | +10.4% |
| 5 y5 years | -5.2% | +39.4% |
FOLD Operating expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -11.6% | +1.2% | at high | +48.0% |
| 5 y | 5-year | -11.6% | +1.2% | at high | +48.0% |
| alltime | all time | -11.6% | +7857.0% | -14.5% | +3611.8% |
FOLD Operating expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | $145.39M(+21.5%) |
| Mar 2025 | - | $119.67M(+2.4%) |
| Dec 2024 | $432.74M(+1.2%) | $116.86M(+15.4%) |
| Sep 2024 | - | $101.27M(+3.1%) |
| Jun 2024 | - | $98.26M(-15.6%) |
| Mar 2024 | - | $116.36M(+10.5%) |
| Dec 2023 | $427.65M(-12.7%) | $105.27M(-1.0%) |
| Sep 2023 | - | $106.36M(+5.8%) |
| Jun 2023 | - | $100.57M(-12.9%) |
| Mar 2023 | - | $115.46M(-2.3%) |
| Dec 2022 | $489.72M(+5.4%) | $118.14M(+17.9%) |
| Sep 2022 | - | $100.24M(-23.9%) |
| Jun 2022 | - | $131.70M(-5.7%) |
| Mar 2022 | - | $139.63M(-2.5%) |
| Dec 2021 | $464.76M(-0.0%) | $143.20M(+35.8%) |
| Sep 2021 | - | $105.44M(+0.2%) |
| Jun 2021 | - | $105.28M(-5.0%) |
| Mar 2021 | - | $110.84M(-9.9%) |
| Dec 2020 | $464.85M(+1.9%) | $122.98M(+13.6%) |
| Sep 2020 | - | $108.27M(+3.8%) |
| Jun 2020 | - | $104.27M(-19.4%) |
| Mar 2020 | - | $129.34M(-4.3%) |
| Dec 2019 | $456.24M(+14.6%) | $135.21M(+37.2%) |
| Sep 2019 | - | $98.57M(-13.2%) |
| Jun 2019 | - | $113.56M(+4.3%) |
| Mar 2019 | - | $108.90M(+13.5%) |
| Dec 2018 | $398.10M(+73.5%) | $95.98M(-43.6%) |
| Sep 2018 | - | $170.09M(+166.5%) |
| Jun 2018 | - | $63.83M(-6.4%) |
| Mar 2018 | - | $68.19M(-8.3%) |
| Dec 2017 | $229.48M(+35.4%) | $74.39M(+19.4%) |
| Sep 2017 | - | $62.29M(+21.4%) |
| Jun 2017 | - | $51.30M(+2.6%) |
| Mar 2017 | - | $50.01M(+1.4%) |
| Dec 2016 | $169.44M(+39.9%) | $49.31M(-1.2%) |
| Sep 2016 | - | $49.93M(+32.8%) |
| Jun 2016 | - | $37.58M(-3.9%) |
| Mar 2016 | - | $39.13M(-1.0%) |
| Dec 2015 | $121.11M | $39.52M(+17.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2015 | - | $33.54M(+31.5%) |
| Jun 2015 | - | $25.51M(+13.2%) |
| Mar 2015 | - | $22.54M(+6.7%) |
| Dec 2014 | $68.66M(+13.8%) | $21.12M(+21.4%) |
| Sep 2014 | - | $17.40M(+18.8%) |
| Jun 2014 | - | $14.65M(-3.1%) |
| Mar 2014 | - | $15.12M(+14.4%) |
| Dec 2013 | $60.34M(-12.6%) | $13.22M(-10.3%) |
| Sep 2013 | - | $14.74M(-5.2%) |
| Jun 2013 | - | $15.55M(-7.5%) |
| Mar 2013 | - | $16.81M(+11.3%) |
| Dec 2012 | $69.04M(-2.4%) | $15.10M(-8.4%) |
| Sep 2012 | - | $16.49M(+183.5%) |
| Jun 2012 | - | $5.82M(+42.1%) |
| Mar 2012 | - | $4.09M(+4.5%) |
| Dec 2011 | $70.74M(+29.3%) | $3.92M(-18.1%) |
| Sep 2011 | - | $4.78M(-28.8%) |
| Jun 2011 | - | $6.72M(+52.7%) |
| Mar 2011 | - | $4.40M(-74.1%) |
| Dec 2010 | $54.70M(-19.6%) | $16.98M(+33.1%) |
| Sep 2010 | - | $12.75M(+4.9%) |
| Jun 2010 | - | $12.16M(-5.1%) |
| Mar 2010 | - | $12.81M(-11.4%) |
| Dec 2009 | $68.05M(+18.5%) | $14.46M(-18.9%) |
| Sep 2009 | - | $17.83M(-4.6%) |
| Jun 2009 | - | $18.69M(+9.5%) |
| Mar 2009 | - | $17.07M(-9.0%) |
| Dec 2008 | $57.43M(+25.4%) | $18.77M(+49.3%) |
| Sep 2008 | - | $12.57M(-10.0%) |
| Jun 2008 | - | $13.97M(+15.2%) |
| Mar 2008 | - | $12.13M(-18.9%) |
| Dec 2007 | $45.80M(-0.2%) | $14.95M(+30.1%) |
| Sep 2007 | - | $11.49M(+15.2%) |
| Jun 2007 | - | $9.97M(+0.4%) |
| Mar 2007 | - | $9.93M |
| Dec 2006 | $45.91M(+123.6%) | - |
| Dec 2005 | $20.53M(+144.9%) | - |
| Dec 2004 | $8.38M(+54.1%) | - |
| Dec 2003 | $5.44M | - |
FAQ
- What is Amicus Therapeutics, Inc. annual total operating expenses?
- What is the all time high annual operating expenses for Amicus Therapeutics, Inc.?
- What is Amicus Therapeutics, Inc. annual operating expenses year-on-year change?
- What is Amicus Therapeutics, Inc. quarterly total operating expenses?
- What is the all time high quarterly operating expenses for Amicus Therapeutics, Inc.?
- What is Amicus Therapeutics, Inc. quarterly operating expenses year-on-year change?
What is Amicus Therapeutics, Inc. annual total operating expenses?
The current annual operating expenses of FOLD is $432.74M
What is the all time high annual operating expenses for Amicus Therapeutics, Inc.?
Amicus Therapeutics, Inc. all-time high annual total operating expenses is $489.72M
What is Amicus Therapeutics, Inc. annual operating expenses year-on-year change?
Over the past year, FOLD annual total operating expenses has changed by +$5.09M (+1.19%)
What is Amicus Therapeutics, Inc. quarterly total operating expenses?
The current quarterly operating expenses of FOLD is $145.39M
What is the all time high quarterly operating expenses for Amicus Therapeutics, Inc.?
Amicus Therapeutics, Inc. all-time high quarterly total operating expenses is $170.09M
What is Amicus Therapeutics, Inc. quarterly operating expenses year-on-year change?
Over the past year, FOLD quarterly total operating expenses has changed by +$47.13M (+47.97%)